Physics Centre of Minho and Porto Universities (CF-UM-UP) and LaPMET Associate Laboratory, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Centre of Chemistry (CQUM), University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Int J Mol Sci. 2022 Nov 16;23(22):14145. doi: 10.3390/ijms232214145.
Superparamagnetic nanoparticles are of high interest for therapeutic applications. In this work, nanoparticles of calcium-doped manganese ferrites (CaMnFeO) functionalized with citrate were synthesized through thermally assisted oxidative precipitation in aqueous media. The method provided well dispersed aqueous suspensions of nanoparticles through a one-pot synthesis, in which the temperature and Ca/Mn ratio were found to influence the particles microstructure and morphology. Consequently, changes were obtained in the optical and magnetic properties that were studied through UV-Vis absorption and SQUID, respectively. XRD and Raman spectroscopy studies were carried out to assess the microstructural changes associated with stoichiometry of the particles, and the stability in physiological pH was studied through DLS. The nanoparticles displayed high values of magnetization and heating efficiency for several alternating magnetic field conditions, compatible with biological applications. Hereby, the employed method provides a promising strategy for the development of particles with adequate properties for magnetic hyperthermia applications, such as drug delivery and cancer therapy.
超顺磁纳米颗粒在治疗应用中具有很高的研究价值。在这项工作中,通过水相热辅助氧化沉淀法合成了用柠檬酸功能化的钙掺杂锰铁氧体(CaMnFeO)纳米颗粒。该方法通过一锅合成提供了分散良好的纳米颗粒水悬浮液,其中温度和 Ca/Mn 比发现会影响颗粒的微观结构和形态。因此,通过紫外-可见吸收和 SQUID 分别研究了光学和磁性能的变化。XRD 和拉曼光谱研究用于评估与颗粒化学计量相关的微结构变化,通过 DLS 研究了在生理 pH 值下的稳定性。纳米颗粒在几种交变磁场条件下表现出高磁化强度和加热效率,适用于生物应用。因此,所采用的方法为开发具有用于磁热疗应用(如药物输送和癌症治疗)的适当性能的颗粒提供了一种很有前途的策略。
ACS Appl Mater Interfaces. 2019-2-7
Mater Sci Eng C Mater Biol Appl. 2016-3-15
J Mater Sci Mater Med. 2014-10
Nanomaterials (Basel). 2019-8-16
J Nanosci Nanotechnol. 2014-1
Int J Mol Sci. 2023-4-21
J Nanobiotechnology. 2022-6-27
Nat Rev Drug Discov. 2021-2